Medical Communications

Launching a first-in-class therapy for an ultra-rare condition: this was a new disease area for our client, and there was no licensed treatment available. Disease awareness was minimal, and so diagnosis rates were low. Our brief was to create an awareness among stakeholders for the need for treatment and develop the launch materials.

The condition was considered ‘low impact’ by many key stakeholders, leading to a reluctance to treat. Our challenge was to give a voice to those affected and overcome entrenched scepticism.

Our client needed to provide an educational programme for a diverse group of European specialists on the warning signs and symptoms of a rare disease. With a short treatment window and a rapidly progressive condition, the programme strategy had to deliver measurable results.

A UK-based client asked us to develop communications that would improve understanding of a product used in an acute setting against a long-established generic. We could see that the new approach offered clear value, but we needed to identify the opportunity succinctly and tell that story convincingly.